RIGEL PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-111.5M |
| Depreciation & Amortization | $1.4M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $13.4M |
| Net Cash from Operating Activities | $-102.8M |
| Investing Activities | |
| Capital Expenditures | $141.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | — |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | — |
| Net Change in Cash | — |
| Free Cash Flow | $-102.9M |